In Australia all of these products are
regulated as medicines and must be entered on the Therapeutic Goods
Administration's (TGA) Australian Register of Therapeutic Goods (ARTG) before
they may be lawfully sold. The labels must be in English and meet Australia’s
standard for medicines labelling. All products to be entered on the ARTG must
have a Sponsor in Australia.
Formulations
Complementary Medicines, Nutritional
& Sports Supplements and Herbal Products may qualify to be registered or
listed depending on ingredients and claims.
Listable complementary medicines and
supplements are considered low risk. To qualify for listing, all ingredients
including excipients must be known and eligible for use in listable medicines
in Australia and claims must be limited to medium or general level health
claims.
Higher risk products, or those making
stronger health claims, are to be registered and must be evaluated by the TGA
before entry on the ARTG.
Full formulation details are required
to be submitted for assessment, preferably using correct botanical names for
the herbal ingredients.
Good
Manufacturing Practice
The
TGA is very specific in its requirements. All manufacturers, whether in Australia or
overseas, must meet pharmaceutical standards of GMP. Australian manufacturers
must be licensed by the TGA. Requirements for overseas manufacturers can be
found in the TGA's Standard of Overseas Manufacturers. GMP Certification may be
accepted for manufacturers in countries with which Australia has a mutual
Recognition Agreement. Only the orignal EU, & EFTA countries, Switzerland
and Canada, have these agreements with Australia. Manufacturers from newer EU
countries, New Zealand and USA must provide extensive documentation and undergo
a "desk audit". If acceptable GMP evidence cannot be obtained, and
for all other countries, an inspection by Australian auditors will be required.
Anyone intending to import these products from overseas should check with us for
advice first before entering into any agreements.
Labelling
and Claims made for the Products
Labelling must conform to the TGA's
general requirements for labelling medicines found in the Therapeutic
Goods Order No 69. Products cannot usually be sold in Australia
in the same labelling that is used overseas. If the product is an imported
product, it can not be approved unless the manufacturer is prepared to provide
special labels for Australia.
Sponsors are required to hold
scientific evidence to support health claims as outlined in the TGA's “Guidelines for the Levels and Kinds of
Evidence to support Claims for Therapeutic Goods".
Getting
Started….
To get started, ADVANTAGEMPC needs a list of the formulations. You can
use our Formulations Form to provide details of the product. Please complete and email or fax us the ADVANTAGE MPC Formulations Form and complete the Free Online
Consultation Form.